• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CDRH names permanent director

Article

Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agency’s Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and

Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agency’s Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and acting director Elizabeth Jacobson (SCAN 3/3/99). Feigal’s new position is effective immediately.

Feigal joined the FDA in 1992, and has served as head of the Center for Drug Evaluation and Research’s division of antiviral drug products and as medical deputy director of the FDA’s Center for Biologics Evaluation and Research. He was a principal investigator in studies that led the FDA to approve a drug-device combination that was one of the earliest therapies for AIDS.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.